Carl Zeiss Meditec (ETR:AFX) Shares Down 1.8% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFXGet Free Report)’s stock price dropped 1.8% during trading on Wednesday . The company traded as low as €25.50 and last traded at €25.78. Approximately 160,411 shares traded hands during trading, an increase of 70% from the average daily volume of 94,405 shares. The stock had previously closed at €26.24.

Carl Zeiss Meditec Price Performance

The company has a current ratio of 2.43, a quick ratio of 2.47 and a debt-to-equity ratio of 29.43. The stock has a market capitalization of $2.31 billion, a price-to-earnings ratio of 13.26, a PEG ratio of 2.83 and a beta of 1.33. The stock has a 50-day moving average price of €26.12 and a 200 day moving average price of €30.80.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.

Featured Stories

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.